Advertisement

The Scientist

» FDA and immunology

Most Recent

image: Obama Signs FDA Bill

Obama Signs FDA Bill

By | July 11, 2012

The new law reauthorizes fees charged to drug and device makers, creates new fees for the approval of generic drugs.

0 Comments

image: Pharma Company Sues FDA

Pharma Company Sues FDA

By | July 10, 2012

The maker of a pregnancy medication takes action against the federal agency for not stopping pharmacies from making and selling cheaper versions of the drug.

2 Comments

image: Ubiquitin Chains in Action

Ubiquitin Chains in Action

By | July 1, 2012

Present in every tissue of the body, ubiquitin appears to be involved in a dizzying array of functions, from cell cycle and division to organelle and ribosome biogenesis, as well as the response to viral infection. The protein plays at least two role

0 Comments

image: A Placebo for Schizophrenia?

A Placebo for Schizophrenia?

By | June 26, 2012

The placebo effect in clinical trials of the mental disorder has increased over the past decade.

1 Comment

image: A Plea to the FDA

A Plea to the FDA

By | June 21, 2012

Protesters crash the BIO conference to protest the delayed approval of a breast cancer drug.

2 Comments

image: New FDA Review Process Debated

New FDA Review Process Debated

By | June 20, 2012

Industry experts discuss the agency’s plans to make the drug approval process more transparent.

0 Comments

image: @Pharma Branching Out

@Pharma Branching Out

By | June 11, 2012

More than half of pharmaceutical companies on Twitter use more than one handle.

0 Comments

image: The Fungus Among Us

The Fungus Among Us

By | June 11, 2012

Researchers find a slew of new fungal species inhabiting the human gut, and suggest a link to an inflammatory bowel disease.

1 Comment

image: Parkinson's Vax Enters Clinical Trials

Parkinson's Vax Enters Clinical Trials

By | June 7, 2012

Researchers in Vienna are starting a Phase I trial on the first ever vaccine with a potential to treat the neurodegenerative disease.

0 Comments

image: FDA OKs Early Stage Trials

FDA OKs Early Stage Trials

By | June 5, 2012

The regulatory agency will allow early-stage breast cancer patients to try experimental drugs previously reserved for those with advanced disease.

1 Comment

Advertisement

Popular Now

  1. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

  2. Most Earth-like Planet Found
  3. Ancient Viruses as Gene Therapy Vectors
  4. Judge Decides on GM Rice Retraction
Advertisement
Advertisement
Life Technologies